Immunologic Impact of Stereotactic Body Radiation Therapy (SBRT) in Renal Cell Carcinoma
Description: 

This is a non-randomized single center pilot trial, treating patient with metastatic RCC with 15 Gy of SBRT to the primary kidney tumor followed by extirpative partial or radical nephrectomy.

Study Number: 

I 212712

Phase: 
Pilot
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT01892930

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.